Nowadays medical technology can treat vitiligo, but because vitiligo is stubborn and difficult to treat, it is recommended that the early and active treatment of the disease can help improve the appearance of the skin, however, vitiligo still has the possibility of recurrence.
The exact cause of vitiligo has not been fully clarified, according to related research, it is considered to be related to autoimmune diseases, neuropsychiatric factors, genetic factors, melanocyte self-destruction and other factors. Vitiligo caused by white patches are likely to occur in exposed areas that are prone to friction and sun exposure, resulting in local skin color loss and whitening.
Topical hormone creams, such as halometasone, mometasone furoate, fluticasone propionate, etc., given under doctor’s supervision in the early stages of the disease, have the effect of preventing proliferation and restoring some of the skin color. Immunosuppressants, such as tacrolimus and pimecrolimus, can restore some skin color.
Generalized, progressive, stressful conditions, with autoimmune diseases, oral hormonal drugs, such as aminotriol prednisolone, can be taken to help control the progression of the disease. In addition to this, light therapy can also be used to restore normal color to some of the white patches.
Vitiligo with stable condition can also be transplanted to the depigmented area by means of surgical transplantation of autologous tissues and melanocytes, which can achieve the purpose of pigment restoration.
To summarize, modern medical technology can treat vitiligo, the early stage of the disease combined with the doctor’s advice to give treatment, can achieve the purpose of pigmentation recovery. However, the recurrence rate of vitiligo is high, such as frequent smoking and drinking, and having chronic infectious diseases themselves, leading to decreased immunity, which may lead to the recurrence of the disease.